Furthermore, LOXL2 is only involved in crosslinking and deposition of fibrillar collagen—the predominant collagen type in our metastatic lung cancer models15—but is not involved in the maturation of non-fibrillar collagens63, which are also present in lung cancers and involved in epithelial tissue immune regulation52. Here, LOXL2 is linked to lung carcinoma.